WallStreetZenWallStreetZen

NASDAQ: TLIS
Talis Biomedical Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TLIS stock forecasts and price targets.

Forecast return on equity

Is TLIS forecast to generate an efficient return?
Company
-1,492.15%
Industry
17.55%
Market
32.69%
TLIS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TLIS forecast to generate an efficient return on assets?
Company
-1,089.34%
Industry
9.15%
TLIS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TLIS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TLIS$8.46N/AN/A
RCEL$10.35$23.00+122.22%Strong Buy
SENS$0.50$2.00+299.20%Buy
TLSI$9.73N/AN/A
SGHT$6.10$5.50-9.84%Buy

Talis Biomedical Stock Forecast FAQ

What is TLIS's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: TLIS) forecast ROE is -1,492.15%, which is considered weak.

If you're new to stock investing, here's how to buy Talis Biomedical stock.

What is TLIS's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: TLIS) forecast ROA is -1,089.34%, which is lower than the forecast US Medical Devices industry average of 9.15%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.